Legend's new CMO will bring in more cell therapy partners; Precision founders get back in Tune together
Mythili Koneru returned to her childhood stomping grounds of New Jersey last Friday to lead the medical operations at Legend Biotech, where she’ll drive the cell therapy maker’s expansion into solid tumors and off-the-shelf options.
Legend will tap into her business development chops, built during a stint at Eli Lilly, as it looks to ink more partnerships on the back of its successful collaboration with Johnson & Johnson‘s Janssen, which helped solidify the biotech as one of the early leaders in cell therapy with the approval of Carvykti.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.